More than half the world’s population calls the Asia Pacific region home—and almost 80% of that population doesn’t have access to affordable healthcare, according to estimates from the United Nations (UN).
In fact, healthcare demand already outstrips supply in the area. And that gap will continue to grow, in line with a rapidly aging population, rising middle class, shortage of qualified healthcare workers and a steadily increasing disease burden.
As the world’s largest healthcare company, Johnson & Johnson believes it has an opportunity—and a responsibility—to tackle these challenges head-on and offer more patients, customers and consumers more accessible, affordable, locally relevant and impactful products and solutions.
Today, Johnson & Johnson celebrates the official opening of its new Asia Pacific headquarters in Singapore, which will help the company achieve that vision and reimagine the future of healthcare in the region.
The new regional headquarters brings together more than 1,400 employees from our pharmaceutical, medical devices and consumer businesses.
Located in Singapore’s Science Park, the complex will house three new key facilities—a Leadership Lab, a Design Lab and a Johnson & Johnson Human Performance Institute—that will spur innovative ways of working in the region and drive deeper collaboration with partners across the entire healthcare ecosystem, including government bodies, healthcare agencies and academic institutions.
Developing healthcare leaders of the future
The Johnson & Johnson Leadership Lab is a state-of-the-art training facility aimed at developing healthcare leaders who have the capability and skills required to thrive in a time of unparalleled complexity and change.
As Johnson & Johnson’s first international Leadership Lab, it will serve as a think tank for innovation, research, exchange and dialogue that will facilitate leaders to navigate through even the toughest challenges in their careers.
With an ambition to deliver 200 classes to 4,000 Asian leaders annually both on-site and virtually, the Leadership Lab will be an ideal platform for people to drive innovative solutions for the future of healthcare everywhere.
The Lab will also open its doors to the wider community of healthcare leaders in Singapore and the region, driving collaborative connections with universities, research groups, governments and healthcare organizations.
With an ambition to deliver 200 classes to 4,000 Asian leaders annually both on-site and virtually, the Lab will be an ideal platform for people to co-create and drive innovative solutions for the future of healthcare everywhere.
Cultivating a healthy workforce
Workplace stress is on the rise in Asia, and in response to the growing demand for employee health and well-being programs, the Singapore headquarters will house the Asia Pacific branch of the Johnson & Johnson Human Performance Institute—the first such facility outside of the United States.
Based on over 30 years of proprietary research and work with top performers, including Olympic gold medalists and Fortune 500 CEOs, the Human Performance Institute will deliver science-based energy management training to help individuals, teams and organizations in Singapore and across the region achieve sustained high performance.
The holistic program is grounded in the tenets of performance psychology, exercise physiology and nutrition, and aims to boost not just productivity at work but also personal performance and quality of life.
The Singapore Institute will be supported by an elite group of coaches who will develop content customized for the Asia Pacific region with the hopes of improving the health and performance of more than 150,000 people by 2020.
Designing the best products
The Singapore headquarters will also be home to Johnson & Johnson’s first Design Lab outside New York City. Fueled by local insights and research, the Lab will focus primarily on creating products and solutions that will spur growth of a regional pipeline of products designed in Asia Pacific for both the region and the entire world.
For more than 130 years, Johnson & Johnson has been unwavering in its relentless pursuit of innovative ideas and solutions that can positively impact the health of people across the world. Staying true to our company Credo, our new regional hub will extend our existing capabilities, bolster our scientific strength and forge new collaborations that will change the trajectory of healthcare for all Asia Pacific peoples.
Contributors: Company Group Chairman for Asia Pacific, Pharmaceuticals Ong Ai Hua; Company Group Chairman for Asia Pacific, Medical Devices Vladimir Makatsaria; and Company Group Chairman for Asia Pacific, Consumer Thibaut Mongon
